[Clinical efficacy and safety of CLAE regimen for refractory/relapsed T cell acute lymphoblastic leukemia/lymphoma: a prospective, multicenter, single-arm study]. [PDF]
Li Y +9 more
europepmc +1 more source
[Clinical characteristics and prognosis of children with T-lineage acute lymphoblastic leukemia: a single-center study]. [PDF]
Chen XY, Wang JY, Jiang H, Zhang WN.
europepmc +1 more source
[Current situation and prospect of minimal residual disease in pediatric T cell acute lymphoblastic leukemia]. [PDF]
Niu FF, Gao C.
europepmc +1 more source
[Prognostic factors in children with acute T-lymphoblastic leukemia: a single-center clinical study of the CCCG-ALL-2015 protocol]. [PDF]
Fu WF, Fang YJ.
europepmc +1 more source
[Dasatinib monotherapy for intramedullary T-lymphocyte blast crisis in chronic myeloid leukemia: a case report]. [PDF]
Zhang Y, Yang JB, Ma YM.
europepmc +1 more source
[Clinicopathological characteristics of the CD8+ T lymphocytes infiltration and its mechanism in distinct molecular subtype of medulloblastoma]. [PDF]
Chai X +7 more
europepmc +1 more source
小鼠MHC-I/MHC-II类分子限制性表位MAGE-3 多肽疫苗的设计及其免疫效应
【目的】 设计小鼠MHC-I/MHC-II类分子限制性表位黑色素瘤抗原-3(MAGE-3)多肽疫苗即包含CD4+-CD8+ T细胞表位的MAGE-3多肽抗原,并探讨其免疫效应65377; 【方法】 采用计算机模拟设计的方法,结合文献资料选择MHC-I/MHC-II类分子限制性表位的MAGE-3多肽65377;采用酶联免疫斑点实验(ELISPOT)65380;细胞毒性实验评价多肽诱导T淋巴细胞的增殖能力及刺激的T淋巴细胞释放细胞因子的能力65377; 【结果】 获得的联合表位多肽序列为FITC ...
doaj
[Daratumumab for the treatment of relapsed T-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a case report]. [PDF]
Wang X +6 more
europepmc +1 more source
[Chronic myelomonocytic leukemia complicated with T-lymphoblastic lymphoma: a case report and literature review]. [PDF]
Yang YZ, Xu WY, Jiao YJ, Guo ZX.
europepmc +1 more source
[Clinical observation of posttransplant lymphoproliferative disorder in a single center]. [PDF]
Qiao ZQ +12 more
europepmc +1 more source

